Current financial headlines

Sharemaestro Newsreel

Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.

Showing
685–720
Headlines
220508
Sources here
6
Companies here
36
Current section United States financial news

Chronological news

Earlier headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Pfizer (PFE) Stock Looks Reasonable On Returns But Stretched On Earnings

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Pfizer stock has delivered a roughly 28% decline over the past five years, yet recent gains and a mixed set of valuation checks …

PFE main company
Sharemaestro market context Price above Trend Line 52 weeks +8.9% PFE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Lexeo Therapeutics (NASDAQ:LXEO) Stock Rating Lowered by Wall Street Zen

Wall Street Zen has downgraded Lexeo Therapeutics (NASDAQ:LXEO) from a "hold" to a "strong sell" rating, despite a broader analyst consensus of "Buy" with an average price target of $18.75. The company's shares opened at $4.84, near its 12-month low, and it reported a …

LXEO main company
Sharemaestro market context Price below Trend Line 52 weeks -1.2% · Next-week setup negative 42.1% LXEO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

OP Bancorp (NASDAQ:OPBK) Lowered to "Hold" Rating by Wall Street Zen

Wall Street Zen downgraded OP Bancorp (NASDAQ:OPBK) from "Buy" to "Hold," although the overall analyst consensus remains "Buy" with a $17.75 price target. The company reported strong quarterly earnings of $0.53 per share and revenue of $25.72 million, both exceeding expectations. Institutional investors hold …

OPBK main company
Sharemaestro market context Trend signal active 52 weeks +12.3% · Next-week setup positive 55.3% OPBK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Guidewire’s New Qusar AI Agent Framework Might Change The Case For Investing In GWRE

Earlier this month, Guidewire Software launched its Qusar release, introducing an Agentic Framework that lets insurers build, deploy, and manage AI agents across policy, claims, billing, and development workflows on Guidewire Cloud Platform. By combining insurance-specific AI agents with tools that can accelerate coding …

GWRE main company
Sharemaestro market context Trend signal started 52 weeks -17.9% · Next-week setup positive 56.6% GWRE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

EnerSys (ENS) Is Up 6.1% After Record Q1 Earnings, Dividend Hike And Completed Buyback Program – Has The Bull Case Changed?

EnerSys recently announced strong fiscal first-quarter 2027 results, including record revenue, net income, a 10% dividend increase, and a completed share buyback program. These results, supported by tariff refunds and tax credits, demonstrate management's confidence in the company's cash generation. The article explores how …

ENS main company
Sharemaestro market context Price above Trend Line 52 weeks +100.8% ENS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Geospace Technologies (NASDAQ:GEOS) Cut to Strong Sell at Wall Street Zen

Wall Street Zen has downgraded Geospace Technologies (NASDAQ:GEOS) from "sell" to "strong sell," while Weiss Ratings maintained a "sell" assessment, resulting in a consensus "Sell" rating from MarketBeat. The company's shares opened at $5.60, close to its one-year low, and it faces negative profitability …

GEOS main company
Sharemaestro market context Price below Trend Line 52 weeks -71.3% GEOS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

iBio (NASDAQ:IBIO) Rating Increased to Hold at Wall Street Zen

Wall Street Zen has upgraded iBio (NASDAQ:IBIO) from a "sell" to a "hold" rating, though the broader analyst consensus remains a "Buy" with a $5.00 average price target. The company recently reported a quarterly loss of $0.07 per share, missing estimates, and its stock …

IBIO main company
Sharemaestro market context Price below Trend Line 52 weeks +80.8% IBIO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Pyxis Oncology, Inc. (NASDAQ:PYXS) Given Average Rating of "Moderate Buy" by Analysts

Analysts have given Pyxis Oncology (NASDAQ:PYXS) a "Moderate Buy" rating, with eight out of ten recommending a buy, one a hold, and one a sell, and an average 12-month price target of $7.50. Recent analyst actions have been mixed, including a downgrade from Wall …

PYXS main company
Sharemaestro market context Trend signal active 52 weeks +124.6% PYXS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

NOVONIX Stock Scheduled to Reverse Split on Thursday, August 27th (NASDAQ:NVX)

NOVONIX Limited (NASDAQ:NVX) is scheduled to execute a 1-for-10 reverse stock split on Thursday, August 27th, with shareholder adjustments taking place after market close on August 26th. The stock recently traded near its 52-week low at $0.44 and has a consensus "Sell" rating from …

NVX main company
Sharemaestro market context Price below Trend Line 52 weeks -69.3% · Next-week setup negative 40.5% NVX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Neumora Therapeutics (NASDAQ:NMRA) Upgraded at Wall Street Zen

Wall Street Zen upgraded Neumora Therapeutics (NASDAQ:NMRA) from a "strong sell" to a "sell" rating, though the overall analyst consensus remains a "Moderate Buy" with an average price target of $6.57. NMRA shares recently dropped by 7.5%, opening at $1.60, and the company reported …

NMRA main company
Sharemaestro market context Price below Trend Line 52 weeks -1.2% NMRA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Northern Oil and Gas (NYSE:NOG) Raised to Buy at Wall Street Zen

Wall Street Zen upgraded Northern Oil and Gas (NYSE:NOG) to a "buy" rating, despite the broader analyst consensus remaining "hold" with an average price target of $30.62. The company's recent quarterly revenue of $745.24 million exceeded expectations, showing a 5.4% year-over-year increase, though earnings …

NOG main company
Sharemaestro market context Price above Trend Line 52 weeks +2.9% NOG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Public Service Enterprise Group (NYSE:PEG) Stock Rating Lowered by Wall Street Zen

Wall Street Zen has downgraded Public Service Enterprise Group (NYSE:PEG) from a "hold" to a "sell" rating. Despite this, the broader analyst consensus remains "hold" with an average price target of $90.23, while the stock opened at $76.08. The company recently beat earnings expectations …

PEG main company
Sharemaestro market context Price below Trend Line 52 weeks -6.2% · Next-week setup positive 55.2% PEG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Reddit (RDDT) Is Joining the S&P 500 —What’s Next for the Company?

Reddit Inc. (NYSE:RDDT) saw its share price climb by 12.63 percent on Friday to close at $178.09 apiece following announcements that it would join the S&P 500 beginning next week. In an updated report on Thursday, the S&P Dow Jones Indices said that Reddit …

RDDT main company
Sharemaestro market context Trend signal active 52 weeks -18.0% RDDT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context